Fangzhou Inc. provides online chronic disease management services in China. The company provides services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It offers H2H services, including online medical consultation services, e-prescription, and prescription refill services through mobile application; healthcare products through online retail pharmacy service platform; and customized content and marketing solutions, as well as operates hospitals. The company was founded in 2015 and is based in Guangzhou, China.
Metrics to compare | 6086 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship6086PeersSector | |
---|---|---|---|---|
P/E Ratio | −5.6x | −1.0x | 12.0x | |
PEG Ratio | 0.04 | 0.08 | 0.03 | |
Price/Book | 36.1x | 2.5x | 1.5x | |
Price / LTM Sales | 1.8x | 1.0x | 0.9x | |
Upside (Analyst Target) | - | 6.4% | 17.9% | |
Fair Value Upside | Unlock | −1.7% | 10.7% | Unlock |